UPDATED Sep 28, 2025
Discover Egyptian Pharmaceuticals & Biotech Growth Stocks that are on the CASE/EGX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
RMDA | ج.م4.20 | 2.9% | 47.4% | ج.م6.3b | ج.م7.30 | PE15.3x | E29.1% | 1.3% | ||
PHAR | ج.م66.01 | 4.6% | 37.4% | ج.م11.1b | ج.م97.90 | PE9.8x | E20.2% | 2.3% | ||
ADCI | ج.م169.76 | -2.5% | 265.5% | ج.م2.0b | n/a | PE12.8x | n/a | 2.5% | ||
NIPH | ج.م81.15 | 5.6% | 12.1% | ج.م2.4b | n/a | PE19.4x | n/a | 4.6% | ||
OCPH | ج.م189.32 | 1.0% | 54.3% | ج.م2.3b | n/a | PE16.1x | n/a | 1.3% | ||
MIPH | ج.م255.52 | 0.4% | 65.3% | ج.م3.0b | n/a | PE13.6x | n/a | 1.0% | ||
MPCI | ج.م137.92 | 0.9% | 266.8% | ج.م3.1b | n/a | PE6.2x | n/a | 2.9% | ||
BIOC | ج.م62.06 | -0.3% | 66.7% | ج.م5.2b | n/a | PE35.4x | n/a | 1.2% | ||
CPCI | ج.م218.19 | -3.2% | 163.4% | ج.م3.3b | n/a | PE7.3x | n/a | 5.9% | ||
SIPC | ج.م2.93 | -14.3% | 169.5% | ج.م732.5m | n/a | PE137.2x | n/a | 0% | ||
AXPH | ج.م699.91 | 1.0% | 205.6% | ج.م3.5b | n/a | PE8.9x | n/a | 4.3% |